Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for trifluoperazine
Most Correlated Studies
- B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
- Lung cancer A549-ACE2 cells and pancreatic organoids treated with different drugs and SARS-CoV-2
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Most Relevant Literature
- Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resista…
- Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis.
- Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen…
- The potent antiplasmodial calmodulin-antagonist trifluoperazine inhibits plasmodium falciparum calci…
- Protective effect of trifluoperazine on hydrogen peroxide-induced apoptosis in PC12 cells.
Most Relevant Clinical Trials
- Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
- The Use of Trifluoperazine in Transfusion Dependent DBA
- Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-af…
